Last reviewed · How we verify
Streptococcal Joint Infection
Approved treatments
- Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Epocelin
- Rocephin · Generic (originally Roche)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Streptococcal Joint Infection patent landscape — cliff calendar, originator estates, attackable patents
- Streptococcal Joint Infection treatment landscape brief
- Streptococcal Joint Infection treatment updates RSS
Frequently asked questions about Streptococcal Joint Infection
What drugs treat Streptococcal Joint Infection?
Tracked treatments include Ceftriaxon, Epocelin, Rocephin.
What is the treatment for Streptococcal Joint Infection?
Standard treatment for Streptococcal Joint Infection includes Ceftriaxon, Epocelin, Rocephin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Streptococcal Joint Infection patent cliff · Streptococcal Joint Infection CI report
- Treatment: Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Treatment: Epocelin
- Treatment: Rocephin · Generic (originally Roche)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing